Nylidrin

Also known as: buphenine, buphenine

Drug #2016

Nylidrin belongs to the group of medicines called vasodilators. Vasodilators increase the size of blood vessels. Nylidrin is used to treat problems due to poor blood circulation.

← Previous drug Next drug →

Primary Characteristics

Nylidrin is also known as buphenine, buphenine.

Molecular Weight: 335.87 · Non-proprietary name: Nylidrin.

Pharmacokinetics

None recorded.

Indications

Nylidrin is primarily indicated in conditions like Arteriosclerosis, Cerebrovascular disease, Peripheral vascular disease, Raynaud's disease, Thromboangiitis obliterans, Thrombophlebitis.

Contraindications

Nylidrin is contraindicated in conditions like Myocardial infarction, Thyrotoxicosis, Tachycardia, Angina pectoris, Hypersensitivity to the drug.

Dosage

Nylidrin's dosage details are as follows:

Dose	Single Dose	Frequency	Route	Instructions
Adult Dosage
7.5 mg	7.5 mg	—	PO	3-4 times daily.
Paediatric Dosage (20kg)
No data.
Neonatal Dosage (3kg)
No data.

Drug Interactions

1 interaction

Always consult your physician for the change of dose regimen or an alternative drug of choice that may strictly be required.

Side Effects

The signs and symptoms that are produced after acute overdosage of Nylidrin are Blurred vision, Fever, Metallic taste, Chest pain.

Nylidrin is known to cause more or less tolerable side effects which are usually transient. These include Chills, Flushing, Headache, Nausea and vomiting, Nervousness, Trembling.

Warnings / Precautions

Warnings and precautions should be considered if the patient have any pre-existing conditions, such as: chest pain, heart disease, thyroid disease, ulcers, any allergies. This medication should be used only if clearly needed during pregnancy. Discuss the risks and benefits with your doctor. It is not known if this medication is found in breast milk. Consult your doctor before breast-feeding. Nylidrin is not indicated in the management of normal aging or of patients with presenile dementia (Alzheimer's Disease).

Available Brands

None recorded.

Storage Conditions

Nylidrin should be stored Tablets.

Drug Classification

1.12.3.7 — Direct vasodilators